It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
It has been reported that a scenario-based cognitive behavioral therapy mobile app including Todac Todac was effective in improving depression in the general public. However, no study has been conducted on whether Todac Todac is effective in dialysis patients. Therefore, this study was intended to determine whether the use of this app was effective in improving depression in dialysis patients. Sixty-five end-stage kidney disease patients receiving dialysis at Soonchunhyang University Cheonan Hospital were randomly assigned to the Todac Todac app program (experimental group) or an E-moods daily mood chart app program (control group) for 3 weeks. The degree of depression was measured before and after using the app.After the end of the 3-week program, a small but significant improvement was observed in the Trait anxiety (p < 0.05) and Beck depression index (p < 0.05) in E-moods group and DAS-K scores (p < 0.05) in Todac Todac group. However, no differences were seen in any parameters between the two groups. In addition, Todac Todac was not statistically more effective than the control intervention in the subgroup analysis. The Todac Todac, a scenario-based cognitive behavioral therapy mobile app, seemed to have a limited effect on improving depression in dialysis patients. Therefore, it is necessary to develop new tools to improve depression in dialysis patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Soonchunhyang University Cheonan Hospital, Department of Internal Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)
2 Soonchunhyang University, Department of Medicine, College of Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)
3 Soonchunhyang University Cheonan Hospital, Department of Biostatistics, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)
4 Soonchunhyang University Cheonan Hospital, Department of Psychiatry, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)
5 Soonchunhyang University Cheonan Hospital, Department of Internal Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524); Soonchunhyang University, Department of Medicine, College of Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)
6 Soonchunhyang University Cheonan Hospital, Department of Internal Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524); Soonchunhyang University, Department of Medicine, College of Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524); Soonchunhyang University, BK21 Four Project, College of Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524); Soonchunhyang University, Institute of Tissue Regeneration, College of Medicine, Cheonan, Korea (GRID:grid.412674.2) (ISNI:0000 0004 1773 6524)